Evidence map›Paper›PMID 35630735›Full record

ArticleMolecules (Basel, Switzerland)2022

Anti-Obesity and Anti-Adipogenic Effects of Administration of Arginyl-Fructose-Enriched Jeju Barley (

Soo-Young Lee, Tae-Yang Kim, Ji-Yoon Hong, Gi-Jung Kim, Jung-Bae Oh, Min-Joo Kim, Emmanouil Apostolidis, Jung-Yun Lee, Young-In Kwon

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Soo-Young LeeDepartment of Food and Nutrition, Hannam University, Daejeon 34054, Korea.
Tae-Yang KimDepartment of Food and Nutrition, Hannam University, Daejeon 34054, Korea.
Ji-Yoon HongDepartment of Food and Nutrition, Hannam University, Daejeon 34054, Korea.
Gi-Jung KimDepartment of Food and Nutrition, Hannam University, Daejeon 34054, Korea.
Jung-Bae OhInstitute of Functional Foods, Kunpoong Bio Co., Ltd., Jeju 63010, Korea.
Min-Joo KimDepartment of Food and Nutrition, Hannam University, Daejeon 34054, Korea.ORCID 0000-0002-4261-9333
Emmanouil ApostolidisDepartment of Chemistry and Food Science, Framingham State University, Framingham, MA 01701, USA.
Jung-Yun LeeDepartment of Chemistry and Food Science, Framingham State University, Framingham, MA 01701, USA.
Young-In KwonDepartment of Food and Nutrition, Hannam University, Daejeon 34054, Korea.ORCID 0000-0002-8069-8212
Hannam University · KRFramingham State University · USHanpoong Pharm (South Korea) · KR

Funding

Korea Institute for Advancement of Technology S2891360
6 · The paper itself

Abstract

In our previous study, we reported that arginyl-fructose (AF), one of the Amadori rearrangement compounds (ARCs) produced by the heat processing of Korean ginseng can reduce carbohydrate absorption by inhibiting intestinal carbohydrate hydrolyzing enzymes in both in vitro and in vivo animal models. This reduced absorption of carbohydrate might be helpful to control body weight gain due to excessive carbohydrate consumption and support induced calorie restriction. However, the weight management effect, except for the effect due to anti-hyperglycemic action, along with the potential mechanism of action have not yet been determined. Therefore, the efforts of this study are to investigate and understand the possible weight management effect and mechanism action of AF-enriched barley extracts (BEE). More specifically, the effect of BEE on lipid accumulation and adipogenic gene expression, body weight gain, body weight, plasma lipids, body fat mass, and lipid deposition were evaluated using C57BL/6 mice and 3T3-L1 preadipocytes models. The formation of lipid droplets in the 3T3-L1 treated with BEE (500 and 750 µg/mL) was significantly blocked (p < 0.05 and p < 0.01, respectively). Male C57BL/6 mice were fed a high-fat diet (30% fat) for 8 weeks with BEE (0.3 g/kg-body weight). Compared to the high fat diet control (HFD) group, the cells treated with BEE significantly decreased in intracellular lipid accumulation with concomitant decreases in the expression of key transcription factors, peroxisome proliferator-activated receptor gamma (PPARγ), CCAAT/enhancer-binding protein alpha (CEBP/α), the mRNA expression of downstream lipogenic target genes such as fatty acid binding protein 4 (FABP4), fatty acid synthase (FAS), and sterol regulatory element-binding protein 1c (SREBP-1c). Supplementation of BEE effectively lowered the body weight gain, visceral fat accumulation, and plasma lipid concentrations. Compared to the HFD group, BEE significantly suppressed body weight gain (16.06 ± 2.44 g vs. 9.40 ± 1.39 g, p < 0.01) and increased serum adiponectin levels, significantly, 1.6-folder higher than the control group. These results indicate that AF-enriched barley extracts may prevent diet-induced weight gain and the anti-obesity effect is mediated in part by inhibiting adipogenesis and increasing adiponectin level.

Indexed as

Anti-Obesity AgentsHordeumObesity3T3-L1 CellsAdipocytesAdipogenesisAdiponectinAnimalsArginineBody WeightCarbohydrate MetabolismFructoseLipid MetabolismMaleMiceMice, Inbred C57BLAdiponectinAnti-Obesity AgentsArginineFructosefructosyl argininePlant ExtractsadipogenicAmadori rearrangement compoundsanti-obesityarginyl-fructosebarley

Identifiers

PMID35630735
PMCPMC9143543
OpenAlexW4280629574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.